Judith A. Sprieser
About Judith A. Sprieser
Independent director at Newell Brands (NWL) since 2018; age 71. She chairs the Audit Committee and serves on the Nominating/Governance Committee. Prior roles include: Managing Director (and later Retired Managing Director) at Warrenton Advisors LLC; Founder, President & CEO of Transora, Inc.; and multiple senior positions at Sara Lee Corporation, including EVP & CFO and CEO of Sara Lee’s Food Group. Current public company directorships include Allstate Insurance Company and Intercontinental Exchange, Inc.; she serves on the NACD Committee for Audit Committee Chairs. She is designated an “audit committee financial expert” under SEC rules.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Warrenton Advisors LLC | Managing Director; later Retired Managing Director | 2005–2019 (MD); 2019–Present (Retired MD) | Strategic planning, corporate governance and financing advisory focus |
| Transora, Inc. | Founder, President & CEO | 2000–2005 | Built and led B2B data/technology consortium in CPG |
| Sara Lee Corporation | EVP & CFO; CEO of Sara Lee’s Food Group; other senior roles | 1995–2000 | Finance and operations leadership in CPG |
External Roles
| Organization | Role | Status/Notes |
|---|---|---|
| Allstate Insurance Company | Director | Current public board |
| Intercontinental Exchange, Inc. | Director | Current public board |
| Experian plc | Director | Former public board |
| Jimmy Choo plc | Director | Former public board |
| Koninklijke Ahold Delhaize N.V. | Director | Former public board |
| Reckitt Benckiser Group plc | Director | Former public board |
| Total Wine & More | Director | Former board |
Board Governance
- Independence, attendance, and structure: The Board’s 2025 review affirmed all non-management director nominees (including Sprieser) are independent under Nasdaq rules. In 2024, the Board met six times; all directors attended at least 75% of Board and applicable committee meetings; non-management directors held four executive sessions. Standing committees: Audit; Compensation & Human Capital; Nominating/Governance.
- Committee assignments (current): Audit Committee (Chair; “audit committee financial expert”); Nominating/Governance Committee. Audit met eight times in 2024; Compensation met six; Nominating/Governance met four.
- Audit Committee remit (selected): Oversees financial statements, compliance, auditor independence and performance (PwC), internal audit, and overall risk management; owns whistleblower procedures; authority to engage advisors.
- Auditor oversight (fees pre-approved by Audit Committee): PwC audit fees declined from $11.6m (FY2023) to $9.1m (FY2024); tax fees $2.4m (2023) vs $2.1m (2024).
- Governance policies: Clawback policy; director and executive stock ownership guidelines; anti-hedging and anti-pledging; majority voting; proxy access; special meeting rights; annual Board/committee/director evaluations.
Fixed Compensation
| Year | Fees Earned or Paid in Cash ($) | Stock Awards ($) | Total ($) |
|---|---|---|---|
| 2023 | 140,000 | 159,994 | 299,994 |
| 2024 | 140,000 | 159,999 | 299,999 |
| Standard Non‑Employee Director Cash Retainers (context) | Amount ($) |
|---|---|
| Annual director retainer | 115,000 |
| Audit Committee Chair additional retainer | 25,000 |
| Nominating/Governance Chair additional retainer | 25,000 |
| Compensation & Human Capital Chair additional retainer | 25,000 |
| Board Chair additional retainer | 115,000 |
Notes: Sprieser’s 2024 cash fees of $140,000 align with director retainer ($115,000) + Audit Chair premium ($25,000).
Performance Compensation
| Grant Date | Award Type | RSUs Granted | Grant Date Fair Value ($) | Vesting | Deferral |
|---|---|---|---|---|---|
| May 16, 2023 | RSUs | 18,285 | 160,000 equivalent (at $8.75/share) | Vest on earlier of 1-year from grant or next annual meeting (if ≥50 weeks after prior annual meeting); service requirement through vest date | Certain directors (Campbell, Johnson, Mather) deferred; no deferral stated for Sprieser |
| May 9, 2024 | RSUs | 19,441 | 159,999 (at $8.23/share) | Vest on earlier of 1-year from grant or next annual meeting (≥50 weeks); service condition | Campbell and Stahl elected to defer; no deferral stated for Sprieser |
Performance metrics tied to director equity: None; director RSUs are time-based and not performance-conditioned.
Other Directorships & Interlocks
- Current public boards: Allstate Insurance Company; Intercontinental Exchange, Inc.
- Former public boards: Experian plc; Jimmy Choo plc; Koninklijke Ahold Delhaize N.V.; Reckitt Benckiser Group plc; Total Wine & More.
- Compensation Committee interlocks: During 2024, Sprieser served on the Compensation & Human Capital Committee; no member was an officer/employee or had related-party transactions requiring disclosure under Item 404.
Expertise & Qualifications
- Financial and operating leadership in consumer-packaged goods; public company board and global experience; NACD audit chairs committee member.
- “Audit committee financial expert” under SEC rules.
Equity Ownership
| As-of Date | Total Beneficial Ownership (shares) | Percent of Class | Unvested RSUs | Notes | |---|---|---:|---|---|---| | Feb 26, 2025 | 30,534 | <1% (“*”) of 417,676,055 outstanding | 19,441 unvested RSUs as of 12/31/2024 | Company prohibits director hedging/pledging; counts toward ownership guidelines include certain deferred units; options not reported for Sprieser
Stock ownership guidelines (alignment):
- Non-Employee Directors must hold stock equal to 5x annual cash retainer.
- Anti-hedging and anti-pledging policies apply to directors.
Governance Assessment
-
Strengths
- Independent director with deep finance/operations experience; designated audit committee financial expert; chairs Audit Committee.
- Strong oversight footprint: Audit met 8x in 2024; auditor fees declined YoY; committee pre-approves all services.
- Alignment mechanisms: Annual time-based RSUs; director ownership guideline at 5x cash retainer; anti-hedge/pledge; clawback policy.
-
Watch items / RED FLAGS
- 2024 Say‑on‑Pay failed (For: 146.8m; Against: 191.0m), signaling investor dissatisfaction with executive pay; Sprieser served on the Compensation & Human Capital Committee during 2024 before committee changes effective May 8, 2024.
- Stockholder push for tighter executive stock retention surfaced in 2025 (Board recommended against); highlights ongoing investor focus on alignment.
-
Conflicts/related parties
- Company’s related‑party review framework is led by Nominating/Governance; 2024 Compensation Committee members (including Sprieser) had no relationships requiring Item 404 disclosure.
Appendix: Board Activity and Auditor Fees (Context)
| Metric | 2023 | 2024 |
|---|---|---|
| Audit Committee meetings | — | 8 |
| Board meetings | — | 6; all directors ≥75% attendance |
| PwC Audit Fees ($m) | 11.6 | 9.1 |
| PwC Tax Fees ($m) | 2.4 | 2.1 |